Innate Pharma S.A. (FRA:IDDA)
1.660
-0.010 (-0.60%)
At close: Dec 4, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €154.10 million as of December 5, 2025. Its market cap has increased by 34.44% in one year.
Market Cap
154.10M
Enterprise Value
121.11M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.66
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 154.10M, an increase of 19,354.51%. That is a compound annual growth rate of 31.77%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 181.89B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |